Company / Current Assets per Share
Serina Therapeutics, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.72
FY2025
5-year range
$0.06 / $7.06
FY2021-FY2025
Trend
-69.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $7.06 to $0.72 over the past 2 years.
Based on SEC 10-K filings.
0.72 in FY2025 with a 5-year CAGR of +64.1%.
Declined from $7.06 to $0.72 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +123.6%
- 5-Year CAGR
- +64.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 69.3% year-over-year.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.72 | -69.3% |
| FY2024 | $2.36 | -66.6% |
| FY2023 | $7.06 | +10821.7% |
| FY2022 | $0.06 | +9.1% |
| FY2021 | $0.06 | -2.3% |
| FY2020 | $0.06 | -73.9% |
| FY2018 | $0.23 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026